KCNH2 and myeloid leukemia: The observation by Masi et al. is supported by other literature, reporting increased ERG1 mRNA expression, elevated protein levels and high densities of ERG1 channels in other tumors, such as colorectal cancer [29], endometrial adenocarcinoma [30], and myeloid leukemia [31].